Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 1996

View Archived Issues

Dual NEP/ACE inhibitors claimed by Eisai

Schering-Plough reveals new NK antagonists

Grelan, Fournier collaborate on ACAT inhibitors

Tetracycline antibacterial agents under study at Pfizer

Fujisawa synthesizes novel bone resorption inhibitors

Mercian discovers other anthracycline antineoplastic agents

FDA medical devices advisory committee to meet today

Company Profile: 3-Dimensional Pharmaceuticals

Milestone reached in Genset-Synthelabo collaboration

Inex and Bayer end antibiotic research collaboration

Genzyme commences cardiovascular gene therapy collaboration

AHP to acquire Genetics Institute

ConXn effective in lung fibrosis

Connective Therapeutics reports progress on interferon gamma

1997 launch anticipated for scar management device from Life Medical Sciences

Genelabs-DuPont Merck joint effort to discover gene-regulating drugs

Liposome formulation of cisplatin enters clinical trials

Company Profile: R.P. Scherer

Autoimmune disease Rx enters clinical trials

Applied Microbiology name change approved

Astra and Eisai terminate legal actions related to proton pump inhibitors

Licensees sought for method of inducing CTL response

NIH offers anticataract invention for licensing

Novel adenylate cyclase offered for licensing

MRC offers licenses for work relating to pathological vasoconstriction

Licensees sought for MAbs specific for P-450 enzymes

Spray formulation of antimigraine Rx cleared for marketing

Cortech regains rights to elastase inhibitor

Pharmacyclics' MRI contrast agent deemed approvable

IND filed for chirally pure ADHD treatment

Possible merger for Sanofi

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...